4.6 Article

Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1

Journal

EXPERIMENTAL CELL RESEARCH
Volume 368, Issue 2, Pages 184-193

Publisher

ELSEVIER INC
DOI: 10.1016/j.yexcr.2018.04.028

Keywords

IL-11; Invasion; Migration; MUC1; CAFs

Funding

  1. Major Project of the Ministry of Science and Technology of China [2017ZX09304025]
  2. National Natural Science Foundation of China [81572374, 81201615]
  3. Department of Education of Liaoning Province [LZ2015073]
  4. Foundation for Selected Overseas Chinese Scholar
  5. Science and Technology Plan Project of Liaoning Province [2016007010, 2015020457]
  6. Key Research and Development Program of Shenyang [17-230-9-01]

Ask authors/readers for more resources

Cancer-associated fibroblasts (CAFs) are major components of the tumor stroma and regulators of tumor progression. However, the molecular mechanism by which CAFs promote gastric cancer progressioh should be further explored. In our study, we found that interleukin-11 (IL-11) secretion was significantly increased when CAFs were co-cultured with gastric cancer cells. Co-culture system-derived IL-11 promoted the migration and invasion of gastric cancer cells, whereas the increase of migration and invasion was attenuated by a neutralizing antibody of IL-11 or inhibition of JAK/STAT3 and MAPIVERK pathways with specific inhibitors. Taken together, these results revealed that CAFs play a significant role in the gastric cancer progression in the tumor micro environment through IL-11-STAT3/ERK signaling by upregulating MUC1. Also, IL-11 targeted therapy can achieve an effective treatment against gastric cancer indirectly by exerting their action on stromal fibroblasts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medical Laboratory Technology

Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer

Jin Wang, Jinglei Qu, Zhi Li, Xiaofang Che, Jing Liu, Yuee Teng, Bo Jin, Mingfang Zhao, Yunpeng Liu, Xiujuan Qu

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)

Article Oncology

DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53-deficient pancreatic cancer cells

Wei Jing, Na Song, Yunpeng Liu, Xiujuan Qu, Kezuo Hou, Xianghong Yang, Xiaofang Che

MOLECULAR MEDICINE REPORTS (2018)

Article Oncology

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

Chenlu Zhang, Zhi Li, Ling Xu, Xiaofang Che, Ti Wen, Yibo Fan, Ce Li, Shuo Wang, Yu Cheng, Xiaoxun Wang, Xiujuan Qu, Yunpeng Liu

BMC CANCER (2018)

Article Oncology

C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells

Wei Li, Ling Xu, Xiaofang Che, Haizhou Li, Ye Zhang, Na Song, Ti Wen, Kezuo Hou, Yi Yang, Lu Zhou, Xing Xin, Lu Xu, Xue Zeng, Sha Shi, Yunpeng Liu, Xiujuan Qu, Yuee Teng

BMC CANCER (2018)

Article Biochemistry & Molecular Biology

E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer

Shuo Wang, Ling Xu, Xiaofang Che, Ce Li, Lu Xu, Kezuo Hou, Yibo Fan, Ti Wen, Xiujuan Qu, Yunpeng Liu

FEBS LETTERS (2018)

Article Oncology

SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer

Lu Xu, Xiaofang Che, Ying Wu, Na Song, Sha Shi, Shuo Wang, Ce Li, Lingyun Zhang, Xinlian Zhang, Xiujuan Qu, Yuee Teng

ONCOLOGY REPORTS (2018)

Article Oncology

Caveolin-1 enhances RANKL-induced gastric cancer cell migration

Yan Wang, Yongxi Song, Xiaofang Che, Lingyun Zhang, Qian Wang, Xiaomeng Zhang, Jinglei Qu, Zhi Li, Ling Xu, Ye Zhang, Yibo Fan, Kezuo Hou, Yunpeng Liu, Xiujuan Qu

ONCOLOGY REPORTS (2018)

Article Oncology

The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells

Yu Cheng, Yongxi Song, Jinglei Qu, Xiaofang Che, Na Song, Yibo Fan, Ti Wen, Ling Xu, Jing Gong, Xiaoxun Wang, Chenlu Zhang, Xiujuan Qu, Yunpeng Liu

TRANSLATIONAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation

Xiaonan Shi, Libao Gong, Yunpeng Liu, Kezuo Hou, Yibo Fan, Ce Li, Ti Wen, Xiujuan Qu, Xiaofang Che

EPIGENETICS (2020)

Article Oncology

PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells

Na Song, Ming Bai, Xiaofang Che, Zhi Li, Wei Jing, Ce Li, Zan Teng, Xiujuan Qu, Yunpeng Liu

MEDICAL ONCOLOGY (2020)

Article Oncology

Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail

Mingming Deng, Bofang Liu, Zhe Zhang, Yang Chen, Yizhe Wang, Ximing Wang, Qingjie Lv, Xianghong Yang, Kezuo Hou, Xiaofang Che, Xiujuan Qu, Yunpeng Liu, Ye Zhang, Xuejun Hu

CANCER SCIENCE (2020)

Review Pharmacology & Pharmacy

Pharmaceutical strategies in improving anti-tumour efficacy and safety of intraperitoneal therapy for peritoneal metastasis

Puxiu Wang, Xiujuan Qu, Xiaofang Che, Qiuhua Luo, Xing Tang, Yunpeng Liu

Summary: Despite showing promising potential in both mouse models and clinical trials, the clinical application of IP therapy for patients with PM is limited due to serious side effects and low acceptability. Further investigations, including pharmaceutical strategies, are needed to develop potential IP therapy solutions that focus on both efficacy and safety.

EXPERT OPINION ON DRUG DELIVERY (2021)

Article Oncology

Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3

Rui Ma, Yunpeng Liu, Xiaofang Che, Ce Li, Ti Wen, Kezuo Hou, Xiujuan Qu

Summary: Colorectal cancers with the BRAF V600E mutation have upregulated PD-L1 expression. This study found that PD-L1 is highly expressed in both the nucleus and cytoplasm. In the nucleus, PD-L1 translocation is facilitated by p-ERK and it interacts with THRAP3 to upregulate BUB1 expression, thus accelerating cell cycle progression and promoting cell proliferation. Additionally, BRAF V600E mutated CRC cells upregulate PD-L1 expression via the transcription factor LEF-1. These findings reveal a novel role of nPD-L1 in promoting cell cycle progression in an immune-independent manner in BRAF V600E mutated CRC.

CANCER LETTERS (2022)

Article Cell Biology

4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation

Xiaonan Shi, Chunlei Zheng, Ce Li, Kezuo Hou, Xiaoxun Wang, Zichang Yang, Chang Liu, Yunpeng Liu, Xiaofang Che, Xiujuan Qu

CELL BIOLOGY INTERNATIONAL (2018)

Article Biology

Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells

S. Zhang, Y. Zhang, J. Qu, X. Che, Y. Fan, K. Hou, T. Guo, G. Deng, N. Song, C. Li, X. Wan, X. Qu, Y. Liu

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2018)

No Data Available